{"count":221304,"next":"https://panelapp-aus.org/api/v1/activities/?format=json&page=1728","previous":"https://panelapp-aus.org/api/v1/activities/?format=json&page=1726","results":[{"created":"2020-07-15T17:51:36.576405+10:00","panel_name":"Disorders of Sex Differentiation","panel_id":99,"panel_version":"0.112","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: LEPR as ready","entity_name":"LEPR","entity_type":"gene"},{"created":"2020-07-15T17:51:36.565425+10:00","panel_name":"Disorders of Sex Differentiation","panel_id":99,"panel_version":"0.112","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: lepr has been classified as Green List (High Evidence).","entity_name":"LEPR","entity_type":"gene"},{"created":"2020-07-15T17:51:34.405136+10:00","panel_name":"Disorders of Sex Differentiation","panel_id":99,"panel_version":"0.112","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: LEPR were changed from  to Obesity, morbid, due to leptin receptor deficiency (MIM#614963)","entity_name":"LEPR","entity_type":"gene"},{"created":"2020-07-15T17:51:02.701602+10:00","panel_name":"Disorders of Sex Differentiation","panel_id":99,"panel_version":"0.111","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: LEPR were set to ","entity_name":"LEPR","entity_type":"gene"},{"created":"2020-07-15T17:50:36.713083+10:00","panel_name":"Disorders of Sex Differentiation","panel_id":99,"panel_version":"0.110","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: LEPR was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"LEPR","entity_type":"gene"},{"created":"2020-07-15T17:48:05.719361+10:00","panel_name":"Disorders of Sex Differentiation","panel_id":99,"panel_version":"0.109","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: FGF17 as ready","entity_name":"FGF17","entity_type":"gene"},{"created":"2020-07-15T17:48:05.708922+10:00","panel_name":"Disorders of Sex Differentiation","panel_id":99,"panel_version":"0.109","user_name":"Zornitza Stark","item_type":"entity","text":"Added comment: Comment when marking as ready: Borderline Green/Amber: contribution may not be monogenic.","entity_name":"FGF17","entity_type":"gene"},{"created":"2020-07-15T17:48:05.681199+10:00","panel_name":"Disorders of Sex Differentiation","panel_id":99,"panel_version":"0.109","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: fgf17 has been classified as Green List (High Evidence).","entity_name":"FGF17","entity_type":"gene"},{"created":"2020-07-15T17:47:55.929234+10:00","panel_name":"Disorders of Sex Differentiation","panel_id":99,"panel_version":"0.109","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: FGF17 were set to ","entity_name":"FGF17","entity_type":"gene"},{"created":"2020-07-15T17:47:01.491878+10:00","panel_name":"Disorders of Sex Differentiation","panel_id":99,"panel_version":"0.108","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: FGF17 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"FGF17","entity_type":"gene"},{"created":"2020-07-15T17:46:35.844832+10:00","panel_name":"Disorders of Sex Differentiation","panel_id":99,"panel_version":"0.107","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: FGF17: Rating: GREEN; Mode of pathogenicity: None; Publications: 23643382, 31748124; Phenotypes: Hypogonadotropic hypogonadism 20 with or without anosmia, MIM# 615270; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"FGF17","entity_type":"gene"},{"created":"2020-07-15T17:42:33.823585+10:00","panel_name":"Disorders of Sex Differentiation","panel_id":99,"panel_version":"0.107","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: LHB as ready","entity_name":"LHB","entity_type":"gene"},{"created":"2020-07-15T17:42:33.811462+10:00","panel_name":"Disorders of Sex Differentiation","panel_id":99,"panel_version":"0.107","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: lhb has been classified as Green List (High Evidence).","entity_name":"LHB","entity_type":"gene"},{"created":"2020-07-15T17:42:30.239110+10:00","panel_name":"Disorders of Sex Differentiation","panel_id":99,"panel_version":"0.107","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: LHB were changed from  to Hypogonadotropic hypogonadism 23 with or without anosmia (MIM#228300)","entity_name":"LHB","entity_type":"gene"},{"created":"2020-07-15T17:42:07.857304+10:00","panel_name":"Disorders of Sex Differentiation","panel_id":99,"panel_version":"0.106","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: LHB were set to ","entity_name":"LHB","entity_type":"gene"},{"created":"2020-07-15T17:41:46.191815+10:00","panel_name":"Disorders of Sex Differentiation","panel_id":99,"panel_version":"0.105","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: LHB was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"LHB","entity_type":"gene"},{"created":"2020-07-15T17:40:56.030156+10:00","panel_name":"Disorders of Sex Differentiation","panel_id":99,"panel_version":"0.104","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: FEZF1 as ready","entity_name":"FEZF1","entity_type":"gene"},{"created":"2020-07-15T17:40:56.020575+10:00","panel_name":"Disorders of Sex Differentiation","panel_id":99,"panel_version":"0.104","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: fezf1 has been classified as Amber List (Moderate Evidence).","entity_name":"FEZF1","entity_type":"gene"},{"created":"2020-07-15T17:40:53.731101+10:00","panel_name":"Disorders of Sex Differentiation","panel_id":99,"panel_version":"0.104","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: FEZF1 were changed from  to Hypogonadotropic hypogonadism 22, with or without anosmia 616030","entity_name":"FEZF1","entity_type":"gene"},{"created":"2020-07-15T17:40:31.244410+10:00","panel_name":"Disorders of Sex Differentiation","panel_id":99,"panel_version":"0.103","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: FEZF1 were set to ","entity_name":"FEZF1","entity_type":"gene"},{"created":"2020-07-15T17:40:08.596697+10:00","panel_name":"Disorders of Sex Differentiation","panel_id":99,"panel_version":"0.102","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: FEZF1 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"FEZF1","entity_type":"gene"},{"created":"2020-07-15T17:39:47.960497+10:00","panel_name":"Disorders of Sex Differentiation","panel_id":99,"panel_version":"0.101","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: FEZF1 as Amber List (moderate evidence)","entity_name":"FEZF1","entity_type":"gene"},{"created":"2020-07-15T17:39:47.953284+10:00","panel_name":"Disorders of Sex Differentiation","panel_id":99,"panel_version":"0.101","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: fezf1 has been classified as Amber List (Moderate Evidence).","entity_name":"FEZF1","entity_type":"gene"},{"created":"2020-07-15T17:39:01.181120+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3349","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: FEZF1 as ready","entity_name":"FEZF1","entity_type":"gene"},{"created":"2020-07-15T17:39:01.173173+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3349","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: fezf1 has been classified as Amber List (Moderate Evidence).","entity_name":"FEZF1","entity_type":"gene"},{"created":"2020-07-15T17:38:54.931278+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3349","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: FEZF1 were changed from  to Hypogonadotropic hypogonadism 22, with or without anosmia, MIM# 616030","entity_name":"FEZF1","entity_type":"gene"},{"created":"2020-07-15T17:38:34.295894+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3348","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: FEZF1 were set to ","entity_name":"FEZF1","entity_type":"gene"},{"created":"2020-07-15T17:38:16.777797+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3347","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: FEZF1 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"FEZF1","entity_type":"gene"},{"created":"2020-07-15T17:38:00.460937+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3346","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: FEZF1 as Amber List (moderate evidence)","entity_name":"FEZF1","entity_type":"gene"},{"created":"2020-07-15T17:38:00.431854+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3346","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: fezf1 has been classified as Amber List (Moderate Evidence).","entity_name":"FEZF1","entity_type":"gene"},{"created":"2020-07-15T17:34:55.370876+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3345","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: ESR2 as ready","entity_name":"ESR2","entity_type":"gene"},{"created":"2020-07-15T17:34:55.355450+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3345","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: esr2 has been classified as Amber List (Moderate Evidence).","entity_name":"ESR2","entity_type":"gene"},{"created":"2020-07-15T17:34:48.754610+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3345","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: ESR2 were changed from  to 46,XY disorder of sex development; Ovarian dysgenesis 8, MIM# 618187","entity_name":"ESR2","entity_type":"gene"},{"created":"2020-07-15T17:34:33.483836+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3344","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: ESR2 were set to ","entity_name":"ESR2","entity_type":"gene"},{"created":"2020-07-15T17:34:07.921934+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3343","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: ESR2 was changed from MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted to BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"ESR2","entity_type":"gene"},{"created":"2020-07-15T17:33:47.810404+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3342","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: ESR2: Rating: AMBER; Mode of pathogenicity: None; Publications: 29261182, 9861029, 30113650; Phenotypes: 46,XY disorder of sex development, Ovarian dysgenesis 8, MIM# 618187; Mode of inheritance: BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"ESR2","entity_type":"gene"},{"created":"2020-07-15T17:32:59.659139+10:00","panel_name":"Congenital Disorders of Glycosylation","panel_id":68,"panel_version":"0.90","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: NUS1 were changed from  to Congenital disorder of glycosylation, type 1aa, MIM#610463","entity_name":"NUS1","entity_type":"gene"},{"created":"2020-07-15T17:31:21.059820+10:00","panel_name":"Disorders of Sex Differentiation","panel_id":99,"panel_version":"0.100","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: ESR2 as ready","entity_name":"ESR2","entity_type":"gene"},{"created":"2020-07-15T17:31:21.051859+10:00","panel_name":"Disorders of Sex Differentiation","panel_id":99,"panel_version":"0.100","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: esr2 has been classified as Amber List (Moderate Evidence).","entity_name":"ESR2","entity_type":"gene"},{"created":"2020-07-15T17:31:18.819631+10:00","panel_name":"Disorders of Sex Differentiation","panel_id":99,"panel_version":"0.100","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: ESR2 were changed from 46,XY Disorders of Sex Development to 46,XY Disorders of Sex Development; Ovarian dysgenesis 8, MIM# 618187","entity_name":"ESR2","entity_type":"gene"},{"created":"2020-07-15T17:30:55.683083+10:00","panel_name":"Disorders of Sex Differentiation","panel_id":99,"panel_version":"0.99","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: ESR2 were set to 29261182; 9861029","entity_name":"ESR2","entity_type":"gene"},{"created":"2020-07-15T17:30:27.541877+10:00","panel_name":"Disorders of Sex Differentiation","panel_id":99,"panel_version":"0.98","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: ESR2 as Amber List (moderate evidence)","entity_name":"ESR2","entity_type":"gene"},{"created":"2020-07-15T17:30:27.532549+10:00","panel_name":"Disorders of Sex Differentiation","panel_id":99,"panel_version":"0.98","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: esr2 has been classified as Amber List (Moderate Evidence).","entity_name":"ESR2","entity_type":"gene"},{"created":"2020-07-15T17:30:04.791460+10:00","panel_name":"Disorders of Sex Differentiation","panel_id":99,"panel_version":"0.97","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: ESR2: Rating: AMBER; Mode of pathogenicity: None; Publications: 30113650; Phenotypes: Ovarian dysgenesis 8, MIM# 618187; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"ESR2","entity_type":"gene"},{"created":"2020-07-15T17:23:09.541023+10:00","panel_name":"Disorders of Sex Differentiation","panel_id":99,"panel_version":"0.97","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: ERAL1 as ready","entity_name":"ERAL1","entity_type":"gene"},{"created":"2020-07-15T17:23:09.530439+10:00","panel_name":"Disorders of Sex Differentiation","panel_id":99,"panel_version":"0.97","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: eral1 has been classified as Red List (Low Evidence).","entity_name":"ERAL1","entity_type":"gene"},{"created":"2020-07-15T17:23:03.839940+10:00","panel_name":"Disorders of Sex Differentiation","panel_id":99,"panel_version":"0.97","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: ERAL1 as Red List (low evidence)","entity_name":"ERAL1","entity_type":"gene"},{"created":"2020-07-15T17:23:03.832910+10:00","panel_name":"Disorders of Sex Differentiation","panel_id":99,"panel_version":"0.97","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: eral1 has been classified as Red List (Low Evidence).","entity_name":"ERAL1","entity_type":"gene"},{"created":"2020-07-15T17:22:40.864902+10:00","panel_name":"Disorders of Sex Differentiation","panel_id":99,"panel_version":"0.96","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: ERAL1: Rating: RED; Mode of pathogenicity: None; Publications: 28449065; Phenotypes: Perrault syndrome 6, MIM# 617565; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"ERAL1","entity_type":"gene"},{"created":"2020-07-15T17:03:47.516792+10:00","panel_name":"Disorders of Sex Differentiation","panel_id":99,"panel_version":"0.96","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: MKKS: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Bardet-Biedl syndrome 6 (MIM#605231), McKusick-Kaufman syndrome (MIM#236700); Mode of inheritance: None","entity_name":"MKKS","entity_type":"gene"},{"created":"2020-07-15T17:01:25.803945+10:00","panel_name":"Disorders of Sex Differentiation","panel_id":99,"panel_version":"0.96","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MKKS as ready","entity_name":"MKKS","entity_type":"gene"},{"created":"2020-07-15T17:01:25.793821+10:00","panel_name":"Disorders of Sex Differentiation","panel_id":99,"panel_version":"0.96","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mkks has been classified as Red List (Low Evidence).","entity_name":"MKKS","entity_type":"gene"},{"created":"2020-07-15T17:01:22.775508+10:00","panel_name":"Disorders of Sex Differentiation","panel_id":99,"panel_version":"0.96","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: MKKS were changed from  to Bardet-Biedl syndrome 6 (MIM#605231); McKusick-Kaufman syndrome (MIM#236700)","entity_name":"MKKS","entity_type":"gene"},{"created":"2020-07-15T17:00:53.029882+10:00","panel_name":"Disorders of Sex Differentiation","panel_id":99,"panel_version":"0.95","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: MKKS were set to ","entity_name":"MKKS","entity_type":"gene"},{"created":"2020-07-15T17:00:28.654647+10:00","panel_name":"Disorders of Sex Differentiation","panel_id":99,"panel_version":"0.94","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: MKKS was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"MKKS","entity_type":"gene"},{"created":"2020-07-15T17:00:10.524566+10:00","panel_name":"Disorders of Sex Differentiation","panel_id":99,"panel_version":"0.93","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: MKKS as Red List (low evidence)","entity_name":"MKKS","entity_type":"gene"},{"created":"2020-07-15T17:00:10.515183+10:00","panel_name":"Disorders of Sex Differentiation","panel_id":99,"panel_version":"0.93","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mkks has been classified as Red List (Low Evidence).","entity_name":"MKKS","entity_type":"gene"},{"created":"2020-07-15T16:41:57.231723+10:00","panel_name":"Congenital Disorders of Glycosylation","panel_id":68,"panel_version":"0.89","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: ST3GAL3 were set to ","entity_name":"ST3GAL3","entity_type":"gene"},{"created":"2020-07-15T16:41:47.889120+10:00","panel_name":"Congenital Disorders of Glycosylation","panel_id":68,"panel_version":"0.88","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CCDC115 as ready","entity_name":"CCDC115","entity_type":"gene"},{"created":"2020-07-15T16:41:47.880921+10:00","panel_name":"Congenital Disorders of Glycosylation","panel_id":68,"panel_version":"0.88","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ccdc115 has been classified as Green List (High Evidence).","entity_name":"CCDC115","entity_type":"gene"},{"created":"2020-07-15T16:41:41.161354+10:00","panel_name":"Congenital Disorders of Glycosylation","panel_id":68,"panel_version":"0.88","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: CCDC115 as Green List (high evidence)","entity_name":"CCDC115","entity_type":"gene"},{"created":"2020-07-15T16:41:41.154252+10:00","panel_name":"Congenital Disorders of Glycosylation","panel_id":68,"panel_version":"0.88","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ccdc115 has been classified as Green List (High Evidence).","entity_name":"CCDC115","entity_type":"gene"},{"created":"2020-07-15T16:40:22.988374+10:00","panel_name":"Congenital Disorders of Glycosylation","panel_id":68,"panel_version":"0.87","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: ST3GAL3 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"ST3GAL3","entity_type":"gene"},{"created":"2020-07-15T16:40:20.775565+10:00","panel_name":"Congenital Disorders of Glycosylation","panel_id":68,"panel_version":"0.86","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: B3GLCT as ready","entity_name":"B3GLCT","entity_type":"gene"},{"created":"2020-07-15T16:40:20.764458+10:00","panel_name":"Congenital Disorders of Glycosylation","panel_id":68,"panel_version":"0.86","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: b3glct has been classified as Green List (High Evidence).","entity_name":"B3GLCT","entity_type":"gene"},{"created":"2020-07-15T16:40:03.279740+10:00","panel_name":"Congenital Disorders of Glycosylation","panel_id":68,"panel_version":"0.86","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: ST3GAL3 as Amber List (moderate evidence)","entity_name":"ST3GAL3","entity_type":"gene"},{"created":"2020-07-15T16:40:03.269627+10:00","panel_name":"Congenital Disorders of Glycosylation","panel_id":68,"panel_version":"0.86","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: st3gal3 has been classified as Amber List (Moderate Evidence).","entity_name":"ST3GAL3","entity_type":"gene"},{"created":"2020-07-15T16:37:44.263751+10:00","panel_name":"Congenital Disorders of Glycosylation","panel_id":68,"panel_version":"0.85","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: B3GLCT as Green List (high evidence)","entity_name":"B3GLCT","entity_type":"gene"},{"created":"2020-07-15T16:37:44.256366+10:00","panel_name":"Congenital Disorders of Glycosylation","panel_id":68,"panel_version":"0.85","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: b3glct has been classified as Green List (High Evidence).","entity_name":"B3GLCT","entity_type":"gene"},{"created":"2020-07-15T16:37:42.890960+10:00","panel_name":"Congenital Disorders of Glycosylation","panel_id":68,"panel_version":"0.84","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: PAPSS2 as ready","entity_name":"PAPSS2","entity_type":"gene"},{"created":"2020-07-15T16:37:42.880889+10:00","panel_name":"Congenital Disorders of Glycosylation","panel_id":68,"panel_version":"0.84","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: papss2 has been classified as Red List (Low Evidence).","entity_name":"PAPSS2","entity_type":"gene"},{"created":"2020-07-15T16:32:40.568392+10:00","panel_name":"Congenital Disorders of Glycosylation","panel_id":68,"panel_version":"0.84","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: TMEM199 as ready","entity_name":"TMEM199","entity_type":"gene"},{"created":"2020-07-15T16:32:40.558005+10:00","panel_name":"Congenital Disorders of Glycosylation","panel_id":68,"panel_version":"0.84","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: tmem199 has been classified as Green List (High Evidence).","entity_name":"TMEM199","entity_type":"gene"},{"created":"2020-07-15T16:32:15.635304+10:00","panel_name":"Congenital Disorders of Glycosylation","panel_id":68,"panel_version":"0.84","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: TMEM199 as Green List (high evidence)","entity_name":"TMEM199","entity_type":"gene"},{"created":"2020-07-15T16:32:15.627418+10:00","panel_name":"Congenital Disorders of Glycosylation","panel_id":68,"panel_version":"0.84","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: tmem199 has been classified as Green List (High Evidence).","entity_name":"TMEM199","entity_type":"gene"},{"created":"2020-07-15T16:31:26.657227+10:00","panel_name":"Congenital Disorders of Glycosylation","panel_id":68,"panel_version":"0.83","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: PAPSS2 were changed from  to Brachyolmia 4 with mild epiphyseal and metaphyseal changes MIM#612847","entity_name":"PAPSS2","entity_type":"gene"},{"created":"2020-07-15T16:31:14.799329+10:00","panel_name":"Congenital Disorders of Glycosylation","panel_id":68,"panel_version":"0.82","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: TRIP11 as ready","entity_name":"TRIP11","entity_type":"gene"},{"created":"2020-07-15T16:31:14.784202+10:00","panel_name":"Congenital Disorders of Glycosylation","panel_id":68,"panel_version":"0.82","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: trip11 has been classified as Red List (Low Evidence).","entity_name":"TRIP11","entity_type":"gene"},{"created":"2020-07-15T16:31:09.420214+10:00","panel_name":"Disorders of Sex Differentiation","panel_id":99,"panel_version":"0.92","user_name":"Crystle Lee","item_type":"entity","text":"reviewed gene: KISS1R: Rating: GREEN; Mode of pathogenicity: None; Publications: 17164310, 31073722, 14573733; Phenotypes: Hypogonadotropic hypogonadism 8 with or without anosmia (MIM#614837); Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"KISS1R","entity_type":"gene"},{"created":"2020-07-15T16:31:04.043426+10:00","panel_name":"Congenital Disorders of Glycosylation","panel_id":68,"panel_version":"0.82","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: PAPSS2 were set to ","entity_name":"PAPSS2","entity_type":"gene"},{"created":"2020-07-15T16:30:28.161648+10:00","panel_name":"Congenital Disorders of Glycosylation","panel_id":68,"panel_version":"0.81","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: PAPSS2 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"PAPSS2","entity_type":"gene"},{"created":"2020-07-15T16:30:07.777527+10:00","panel_name":"Congenital Disorders of Glycosylation","panel_id":68,"panel_version":"0.80","user_name":"Ain Roesley","item_type":"entity","text":"gene: CCDC115 was added\ngene: CCDC115 was added to Congenital Disorders of Glycosylation. Sources: Literature\nMode of inheritance for gene: CCDC115 was set to BIALLELIC, autosomal or pseudoautosomal\nPublications for gene: CCDC115 were set to 26833332\nPhenotypes for gene: CCDC115 were set to Congenital disorder of glycosylation, type IIo (MIM# \t616828)\nPenetrance for gene: CCDC115 were set to unknown\nReview for gene: CCDC115 was set to GREEN\nAdded comment: PMID: 26833332\r\n- 8 affecteds from 5 families. Abnormal N-and mucin type O-glycosylation was found on serum proteins, and reduced metabolic labeling of sialic acids was found in fibroblasts. \nSources: Literature","entity_name":"CCDC115","entity_type":"gene"},{"created":"2020-07-15T16:30:03.973567+10:00","panel_name":"Congenital Disorders of Glycosylation","panel_id":68,"panel_version":"0.80","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: PAPSS2 as Red List (low evidence)","entity_name":"PAPSS2","entity_type":"gene"},{"created":"2020-07-15T16:30:03.964087+10:00","panel_name":"Congenital Disorders of Glycosylation","panel_id":68,"panel_version":"0.80","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: papss2 has been classified as Red List (Low Evidence).","entity_name":"PAPSS2","entity_type":"gene"},{"created":"2020-07-15T16:29:22.357719+10:00","panel_name":"Congenital Disorders of Glycosylation","panel_id":68,"panel_version":"0.79","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: TRIP11 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"TRIP11","entity_type":"gene"},{"created":"2020-07-15T16:29:12.840852+10:00","panel_name":"Congenital Disorders of Glycosylation","panel_id":68,"panel_version":"0.78","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: ALG2 as ready","entity_name":"ALG2","entity_type":"gene"},{"created":"2020-07-15T16:29:12.831187+10:00","panel_name":"Congenital Disorders of Glycosylation","panel_id":68,"panel_version":"0.78","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: alg2 has been classified as Red List (Low Evidence).","entity_name":"ALG2","entity_type":"gene"},{"created":"2020-07-15T16:29:04.519263+10:00","panel_name":"Congenital Disorders of Glycosylation","panel_id":68,"panel_version":"0.78","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: NUS1 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"NUS1","entity_type":"gene"},{"created":"2020-07-15T16:28:43.035382+10:00","panel_name":"Congenital Disorders of Glycosylation","panel_id":68,"panel_version":"0.77","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: NUS1 as Amber List (moderate evidence)","entity_name":"NUS1","entity_type":"gene"},{"created":"2020-07-15T16:28:43.028536+10:00","panel_name":"Congenital Disorders of Glycosylation","panel_id":68,"panel_version":"0.77","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nus1 has been classified as Amber List (Moderate Evidence).","entity_name":"NUS1","entity_type":"gene"},{"created":"2020-07-15T16:27:32.197257+10:00","panel_name":"Congenital Disorders of Glycosylation","panel_id":68,"panel_version":"0.76","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: TRIP11 were set to ","entity_name":"TRIP11","entity_type":"gene"},{"created":"2020-07-15T16:27:17.916162+10:00","panel_name":"Congenital Disorders of Glycosylation","panel_id":68,"panel_version":"0.76","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: ALG2 were changed from  to Congenital disorder of glycosylation, type Ii (MIM# 607906)","entity_name":"ALG2","entity_type":"gene"},{"created":"2020-07-15T16:26:56.503278+10:00","panel_name":"Congenital Disorders of Glycosylation","panel_id":68,"panel_version":"0.75","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: ALG2 were set to ","entity_name":"ALG2","entity_type":"gene"},{"created":"2020-07-15T16:26:41.500631+10:00","panel_name":"Congenital Disorders of Glycosylation","panel_id":68,"panel_version":"0.74","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: TRIP11 as Red List (low evidence)","entity_name":"TRIP11","entity_type":"gene"},{"created":"2020-07-15T16:26:41.491265+10:00","panel_name":"Congenital Disorders of Glycosylation","panel_id":68,"panel_version":"0.74","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: trip11 has been classified as Red List (Low Evidence).","entity_name":"TRIP11","entity_type":"gene"},{"created":"2020-07-15T16:26:19.304269+10:00","panel_name":"Congenital Disorders of Glycosylation","panel_id":68,"panel_version":"0.73","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: TRIP11: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Achondrogenesis, type IA MIM# 200600, Osteochondrodysplasia MIM# 184260; Mode of inheritance: None","entity_name":"TRIP11","entity_type":"gene"},{"created":"2020-07-15T16:24:14.340626+10:00","panel_name":"Congenital Disorders of Glycosylation","panel_id":68,"panel_version":"0.73","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: ALG2 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"ALG2","entity_type":"gene"},{"created":"2020-07-15T16:23:56.660332+10:00","panel_name":"Congenital Disorders of Glycosylation","panel_id":68,"panel_version":"0.72","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: ATP6AP1 as ready","entity_name":"ATP6AP1","entity_type":"gene"},{"created":"2020-07-15T16:23:56.650258+10:00","panel_name":"Congenital Disorders of Glycosylation","panel_id":68,"panel_version":"0.72","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: atp6ap1 has been classified as Green List (High Evidence).","entity_name":"ATP6AP1","entity_type":"gene"},{"created":"2020-07-15T16:23:54.520451+10:00","panel_name":"Congenital Disorders of Glycosylation","panel_id":68,"panel_version":"0.72","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: ATP6AP1 as Green List (high evidence)","entity_name":"ATP6AP1","entity_type":"gene"}]}